DHFR and coinfection: There are a number of clinical and epidemiological variables such as transmission, regional drug administration policies, and target populations (ie. pregnant women, co-infections, etc.)that may better explain the reported frequency of the dhfr triple mutant and dhps double mutant genotypes but could not be examined in this analysis.